IC Optix wins a US patent for film overlay of labels
For regulatory as well as marketing reasons, pharma manufacturers tend to pack an excessive amount of information onto the labels attached to pill bottles, package cartons and other containers. This creates problems for patients, especially the elderly, who will either grab a magnifying lens to attempt to read the label, or give up on the label content altogether. To address these concerns, Jim Rittenburg, founder of IC Optix (Perkasie, PA) has developed a transparent, thin-film technology that magnifies underlying text. The technology is recently patented (US Patent No. 8947794 B2) and is being shopped around both pharma and OTC manufacturers, as well as contract packagers.
According to Rittenburg, who has had a career in authentication technologies for labels in healthcare products and consumer goods, the flexible, transparent film provides magnification by using an optical technology known as the Fresnel lens. The 50-75-micron film can be attached directly to the label, or to another location on the package from which it can be peeled and applied elsewhere on the package. As the film is lifted from the underlying label, the label is magnifies 2-3X (more is possible). In the process of molding the film, a visible watermark-like feature can be added to provide an authentication element to the package.
Rittenburg says that commercial-scale production is possible with one of IC-Optix’ partners, and discussions are ongoing with brand owners and packagers. A sampling program is expected to occur with a potential client by year-end. One promising potential application is use with prefilled syringes, some of which are already distributed with several patient-friendly convenience elements.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.